3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Prostatic Neoplasms
2
Motor Activity
2
Breast Neoplasms
2
Urologic Neoplasms
1
Testicular Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Rectal Neoplasms
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neuromuscular Diseases
1
Neoplasm Metastasis
1
Myotonic Dystrophy
1
Myositis, Inclusion Body
1
Muscular Dystrophy, Facioscapulohumeral
1
Muscular Dystrophies, Limb-Girdle
1
Muscular Atrophy, Spinal
1
Multiple Myeloma
1
Lymphoma, B-Cell
1
Lymphedema
1
Lung Neoplasms
1
Low Anterior Resection Syndrome
1
Lambert-Eaton Myasthenic Syndrome
1
Kidney Neoplasms
1
Hereditary Sensory and Motor Neuropathy
1
Guillain-Barre Syndrome
1
Interventions
Bevacizumab
69
atezolizumab
54
lenvatinib
42
durvalumab
42
Nivolumab
38
pembrolizumab
35
tremelimumab
28
Magnetic Resonance Spectroscopy
21
Specimen Handling
19
tislelizumab
18
sintilimab
17
Ipilimumab
15
Sorafenib
14
regorafenib
13
cabozantinib
13
Radiosurgery
13
Radiotherapy
12
apatinib
11
Blood Specimen Collection
11
Immunoglobulin G
10
camrelizumab
9
Immune Checkpoint Inhibitors
9
Disulfides
9
X-Rays
8
Cyclophosphamide
8
donafenib
7
Oxaliplatin
7
Immunotherapy
7
Folfox protocol
7
Fluorouracil
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Physical Therapy Modalities
×
1 year
×
Clear all
No trials found.